title: Long-acting injectable risperidone in treatment refractory patients: a 14-week open-label pilot study.
authors.forename: Ric M
authors.initials: RM
authors.lastname: Procyshyn
authors.forename: Alasdair M
authors.initials: AM
authors.lastname: Barr
authors.forename: Sean
authors.initials: S
authors.lastname: Flynn
authors.forename: Chris
authors.initials: C
authors.lastname: Schenk
authors.forename: Soma
authors.initials: S
authors.lastname: Ganesan
authors.forename: William G
authors.initials: WG
authors.lastname: Honer
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology*; D012008:Recurrence; D018967:Risperidone / Q000008:administration & dosage / Q000627:therapeutic use*; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018967:Risperidone